DOD Biotech Past Earnings Performance

Past criteria checks 0/6

DOD Biotech's earnings have been declining at an average annual rate of -39.5%, while the Personal Products industry saw earnings growing at 11.1% annually. Revenues have been declining at an average rate of 11.2% per year. DOD Biotech's return on equity is 3%, and it has net margins of 4.8%.

Key information

-39.5%

Earnings growth rate

-39.9%

EPS growth rate

Personal Products Industry Growth	3.7%
Revenue growth rate	-11.2%
Return on equity	3.0%
Net Margin	4.8%
Last Earnings Update	31 Dec 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How DOD Biotech makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

SET:DOD-R Revenue, expenses and earnings (THB Millions)
Date	Revenue	Earnings	G+A Expenses
31 Dec 24	662	32	209
30 Sep 24	709	20	263
30 Jun 24	725	18	270
31 Mar 24	760	38	267
31 Dec 23	693	58	199
30 Sep 23	588	-324	185
30 Jun 23	562	-336	168
31 Mar 23	509	-362	174
31 Dec 22	548	-343	163
30 Sep 22	696	51	164
30 Jun 22	713	76	158
31 Mar 22	824	87	144
31 Dec 21	1,018	237	128
30 Sep 21	1,171	311	112
30 Jun 21	1,276	367	107
31 Mar 21	1,254	412	108
31 Dec 20	1,080	280	107
30 Sep 20	1,024	177	238
30 Jun 20	953	112	308
31 Mar 20	856	68	325
31 Dec 19	796	87	330
30 Sep 19	535	88	199
30 Jun 19	472	141	124
31 Mar 19	577	235	112
31 Dec 18	670	305	105
30 Sep 18	701	323	107
30 Jun 18	621	277	100
31 Mar 18	506	220	87
31 Dec 17	389	142	83
30 Sep 17	368	130	73
31 Dec 16	368	139	60
31 Dec 15	385	129	50
31 Dec 14	170	47	18

Quality Earnings: DOD-R has a large one-off gain of THB29.0M impacting its last 12 months of financial results to 31st December, 2024.

Growing Profit Margin: DOD-R's current net profit margins (4.8%) are lower than last year (8.4%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: DOD-R's earnings have declined by 39.5% per year over the past 5 years.

Accelerating Growth: DOD-R's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: DOD-R had negative earnings growth (-45.5%) over the past year, making it difficult to compare to the Personal Products industry average (2.6%).

Return on Equity

High ROE: DOD-R's Return on Equity (3%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/03/13 22:52
End of Day Share Price	2025/03/13 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

DOD Biotech Public Company Limited is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Wilasinee Boonmasungsong	Globlex Securities Co. Ltd.
Hathaichanoke Moonwong	Phillip Securities (Thailand) PCL
Apichat Poobunjirdkul	Tisco Securities Co. Ltd.